PhRMA companies commit to clinical results for discontinued drugs on websites
This article was originally published in Scrip
Executive Summary
Beginning on October 1st, members of the US trade group PhRMA will commit to provide on a public website summaries of safety and effectiveness data for clinical trials in patients whenever drug development has been discontinued, which should allow more medical research transparency.